Novavax COVID vaccine OK’d in Europe after months of delays

It’s a boost for Novavax, which has suffered months of delays despite securing some of the largest funding in the early stages of the pandemic.

from Sydney Morning Herald - World https://ift.tt/3shPb18

Comments

Popular posts from this blog

Gokaldas Exports reports 152% jump in revenues

US largest source of FDI in FY23; Mauritius, UK next